Moneycontrol PRO

business

Elara's take on top pharma stocks: Ranbaxy, DRL, Cipla

Surajit Pal, Pharma Analyst at Elara Capital, in an interview with CNBC-TV18's Latha Venkatesh and Sonia Shenoy, spoke about his reading of the pharma sector and his outlook on a few stocks.

first published: May 5, 2011 01:42 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347